Skip to main content
SpringerLink
Log in

The Cambridge Examination for Mental Disorders of Older People with Down’s Syndrome and Others with Intellectual Disabilities (CAMDEX-DS)

  • Chapter
  • First Online:
Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities

Abstract

The Cambridge Examination for Mental Disorders of Older People with Down’s Syndrome and Others with Intellectual Disabilities (CAMDEX-DS) is a diagnostic assessment schedule developed in response to an identified need for valid and reliable methods for the assessment and diagnosis of dementia in people with intellectual disability (ID). While the increased risk of dementia in people with Down syndrome (DS) in particular means that the schedule is especially valuable for use in this population, it can also been used when dementia is suspected in those with developmentally acquired ID for reasons other than that of DS. Accurate and consistent diagnosis is essential for both clinical practice and research and will be increasingly important as effective treatments for dementia become available.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aylward E, Burt D, Thorpe L, et al. Diagnosis of dementia in individuals with intellectual disability: report of the task force for development of criteria for diagnosis of dementia in individuals with mental retardation. J Intellect Disabil Res. 1997;41:152–64.

    Article  PubMed  Google Scholar 

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorder. Washington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  3. World Health Organisation. ICD-10 international statistical classification of diseases and related health problems. 10th ed. Geneva: WHO; 1992.

    Google Scholar 

  4. Roth M, Huppert FA, Mountjoy CQ, et al. CAMDEX-R: the cambridge examination for mental disorders of the elderly (revised). Cambridge: Cambridge University Press; 1998.

    Google Scholar 

  5. Roth M, Tym E, Mountjoy C, et al. CAMDEX—a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698–709.

    Article  CAS  PubMed  Google Scholar 

  6. Roth M, Huppert F, Tym E, et al. CAMDEX: the cambridge examination for mental disorder of the elderly. Cambridge: Cambridge University Press; 1988.

    Google Scholar 

  7. Neri M, Roth M, Vreese LPD, et al. The validity of informant reports in assessing the severity of dementia: evidence from the CAMDEX interview. Dementia Geriatr Cognit Disord. 1998;9:56–62.

    Article  CAS  Google Scholar 

  8. Huppert FA, Brayne C, Gill C, et al. CAMCOG—a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol. 1995;34:529–41.

    Article  PubMed  Google Scholar 

  9. Huppert FA, Jorm AF, Brayne C, et al. Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia. Aging Neuropsychol Cogn. 1996;3:201–14.

    Article  Google Scholar 

  10. Williams JG, Huppert FA, Matthews FE, et al. Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. Int J Geriatr Psychiatry. 2003;18:631–44.

    Article  PubMed  Google Scholar 

  11. Heinik J. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia. Int Psychogeriatr. 1998;10:103–8.

    Article  CAS  PubMed  Google Scholar 

  12. Jobst K, Smith A, Szatmari M, et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet. 1992;340:1179–83.

    Article  CAS  PubMed  Google Scholar 

  13. Mate KE, Kerr KP, Pond D, et al. Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia. Drugs Aging. 2015;32:159–67.

    Article  CAS  PubMed  Google Scholar 

  14. Clarke MCJ, Anderson J. The prevalence of dementia in a total population: A comparison of two screening instruments. Aging. 1991;20:396–403.

    CAS  Google Scholar 

  15. Cullum S, Huppert FA, McGee M, et al. Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG. Int J Geriatr Psychiatry. 2000;15:853–62.

    Article  CAS  PubMed  Google Scholar 

  16. O’Connor D, Pollitt P, Hyde J, et al. The prevalence of dementia as measured by the Cambridge mental disorders of the elderly examination. Acta Psychol Scand. 1989;79:190–8.

    Article  Google Scholar 

  17. Schmand B, Walstra G, Lindeboom J, et al. Early detection of Alzheimer’s disease using the Cambridge cognitive examination (CAMCOG). Psychol Med. 2000;30:619–27.

    Article  CAS  PubMed  Google Scholar 

  18. Heinik J, Solomesh I, Berkman P. Correlation between the CAMCOG, the MMSE, and three clock drawing tests in a specialized outpatient psychogeriatric service. Arch Gerontol Geriatr. 2004;38:77–84.

    Article  PubMed  Google Scholar 

  19. Nielsen H, Lolk A, Andersen K, et al. Characteristics of elderly who develop Alzheimer’s disease during the next two years—a neuropsychological study using CAMCOG: the odense study. Int J Geriatr Psychiatry. 1999;14:957–63.

    Article  CAS  PubMed  Google Scholar 

  20. Cecato JF, Fiorese B, Montiel JM, et al. Clock drawing test in elderly individuals with different education levels: correlations with clinical dementia rating. Am J Alzheimers Dis Other Demen. 2012;27:620–4.

    Article  PubMed  Google Scholar 

  21. Forstl H, Burns A, Jacoby R, et al. Neuroanatomical correlates of clinical misidentification and misperception in senile dementia of the Alzheimer type. J Clin Psychopharmacol. 1991;52:268–71.

    CAS  Google Scholar 

  22. Gertz H, Xuereb J, Huppert F, et al. The relationship between clinical dementia and neuropathological staging (BRAAK) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci. 1996;246:132–6.

    Article  CAS  PubMed  Google Scholar 

  23. Mak E, Su L, Williams GB, et al. Differential atrophy of hippocampal subfields: a comparative study of dementia with Lewy bodies and Alzheimer disease. Am J Geriatr Psychiatry. 2016;24:136–43.

    Article  PubMed  Google Scholar 

  24. Cabranes J, De Juan R, Encinas M, et al. Relevance of functional neuroimaging in the progression of mild cognitive impairment. Neurol Res. 2004;26:496–501.

    Article  PubMed  Google Scholar 

  25. Hunter R, McLuskie R, Wyper P, et al. The patterns of function-related cerebral blood flow investigated by single photon emission tomography with 99 m Tc-HMPAO in patients with presenile Alzheimer’s disease and Korsakoff’s psychosis. Psychol Med. 1989;19:847–55.

    Article  CAS  PubMed  Google Scholar 

  26. Azevedo D, Tatsch M, Hototian SR, et al. Proton spectroscopy in Alzheimer’s disease and cognitive impairment no dementia: a community-based study. Dementia Geriatr Cognit Disord. 2008;25:491–500.

    Article  CAS  Google Scholar 

  27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.

    Article  CAS  PubMed  Google Scholar 

  28. Saxton J, McGonigle KL, Swihart AA, et al. The Severe impairment battery. Bury St. Edmunds: Thames Valley Test Company; 1993.

    Google Scholar 

  29. Witts P, Elders S. The ‘severe impairment battery’: assessing cognitive ability in adults with Down syndrome. Br J Clin Psychol. 1998;37:213–6.

    Article  PubMed  Google Scholar 

  30. Ball SL, Holland AJ, Huppert FA, et al. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down’s syndrome. J Intellect Disabil Res. 2004;48:611–20.

    Article  CAS  PubMed  Google Scholar 

  31. Deb S, Braganza J. Comparison of rating scales for the diagnosis of dementia in adults with Down’s syndrome. J Intellect Disabil Res. 1999;43:400–7.

    Article  PubMed  Google Scholar 

  32. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.

    Article  CAS  PubMed  Google Scholar 

  33. Hon J, Huppert FA, Holland AJ, et al. Neuropsychological assessment of older adults with Down’s syndrome: an epidemiological study using the Cambridge cognitive examination (CAMCOG). Br J Clin Psychol. 1999;38:155–65.

    Article  PubMed  Google Scholar 

  34. Folstein M, Folstein S, McHugh P. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychol Res. 1975;12:189–98.

    Article  CAS  Google Scholar 

  35. Hewitt KE, Carter G, Jancar J. Ageing in Down’s syndrome. Br J Psychiatry. 1985;147:58–62.

    Article  CAS  PubMed  Google Scholar 

  36. Holland AJ, Hon J, Huppert FA, et al. Population-based study of the prevalence and presentation of dementia in adults with Down’s syndrome. Br J Psychiatry. 1998;172:493–8.

    Article  CAS  PubMed  Google Scholar 

  37. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849–53.

    Article  CAS  PubMed  Google Scholar 

  38. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol. 1985;17:278–82.

    Article  CAS  PubMed  Google Scholar 

  39. Gregory CA, Hodges JR. Dementia of frontal type and the focal lobar atrophies. Int Rev Psychiatry. 1993;5:397–406.

    Article  Google Scholar 

  40. Holland AJ, Hon J, Huppert FA, et al. Incidence and course of dementia in people with Down’s syndrome: findings from a population-based study. J Intellect Disabil Res. 2000;44:138–46.

    Article  PubMed  Google Scholar 

  41. Crome L, Stern L. Pathology of mental retardation. Baltimore, MD: Williams and Wilkins; 1972.

    Google Scholar 

  42. Ball SL, Holland AJ, Hon J, et al. Personality and behaviour changes mark the early stages of Alzheimer’s disease in adults with Down’s syndrome: findings from a prospective population-based study. Int J Geriatr Psychiatry. 2006;21:661–73.

    Article  PubMed  Google Scholar 

  43. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998;64:588–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Prasher VP, Farooq A, Holder R. The adaptive behaviour dementia questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer’s disease in adults with Down syndrome. Res Dev Disabil. 2004;25:385–97.

    Article  CAS  PubMed  Google Scholar 

  45. Prasher VP, Barber PC, West R, et al. The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome. Arch Neurol. 1996;53:1310–3.

    Article  CAS  PubMed  Google Scholar 

  46. Rubinsztein DC, Hon J, Stevens F, et al. Apo E genotypes and risk of dementia in Down syndrome. Am J Med Genet B Neuropsychiatr Genet. 1999;88:344–7.

    Article  CAS  Google Scholar 

  47. Ball SL, Holland AJ, Watson PC, et al. Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer’s disease in people with Down’s syndrome: potential involvement of multiple frontal-subcortical neuronal circuits. J Intellect Disabil Res. 2010;54:320–36.

    Article  CAS  PubMed  Google Scholar 

  48. Landt J, Ball SL, Holland AJ, et al. Age-related changes in plasma dehydroepiandrosterone levels in adults with Down’s Syndrome and the risk of dementia. J Neuroendocrinol. 2011;23:450–5.

    Article  CAS  PubMed  Google Scholar 

  49. Annus T, Wilson LR, Hong YT, et al. The pattern of amyloid accumulation in the brains of adults with Down syndrome. Alzheimers Dement. 2016;12:538–45.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Beacher F, Simmons A, Daly E, et al. Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2005;62:1360–5.

    Article  PubMed  Google Scholar 

  51. Hassiotis A, Strydom A, Allen K, et al. A memory clinic for older people with intellectual disabilities. Aging Ment Health. 2003;7:418–23.

    Article  CAS  PubMed  Google Scholar 

  52. Oliver C, Crayton L, Holland A, et al. A four year prospective study of age-related cognitive change in adults with Down’s syndrome. Psychol Med. 1998;28:1365–77.

    Article  CAS  PubMed  Google Scholar 

  53. Fonseca LM, Oliveira MC, Guilhoto LMFF, et al. Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome. Neuropsychiatr Dis Treat. 2014;10:2209–19.

    Article  PubMed  PubMed Central  Google Scholar 

  54. McPaul A, Walker B, Law J et al. (2016) An exploratory study investigating how adults with intellectual disabilities perform on the visual association test (VAT). J Appl Res Intellect Disabil (Epub ahead of print)

    Google Scholar 

  55. Esteba-Castillo S, Dalmau-Bueno A, Ribas-Vidal N, et al. Adaptation and validation of CAMDEX-DS (Cambridge examination for mental disorders of older people with Down’s syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities. Rev Neurol. 2013;57:337–46.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Psiquiatria do Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil

    Luciana Mascarenhas Fonseca MSc

  2. Department of Psychiatry, University of Cambridge, Cambridge, UK

    Sarah L. Ball DM, FRCP, FRCPath, FRCPCH & Anthony J. Holland MBBS, MRCP, MRCPsych, MPhil

Authors
  1. Luciana Mascarenhas Fonseca MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah L. Ball DM, FRCP, FRCPath, FRCPCH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anthony J. Holland MBBS, MRCP, MRCPsych, MPhil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony J. Holland MBBS, MRCP, MRCPsych, MPhil .

Editor information

Editors and Affiliations

  1. Visiting Professor of Neuropsychiatry, Birmingham, United Kingdom

    Vee P. Prasher

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Fonseca, L.M., Ball, S.L., Holland, A.J. (2018). The Cambridge Examination for Mental Disorders of Older People with Down’s Syndrome and Others with Intellectual Disabilities (CAMDEX-DS). In: Prasher, V. (eds) Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-319-61720-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61720-6_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61719-0

  • Online ISBN: 978-3-319-61720-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation